Skip to NavigationSkip to content

Pharmafile - News News

It seems like 2018 may well be the year for M&A that everyone had expected, as two major deals on the same day announced that acquisitions were...
In a step towards improving patients’ access to its treatment for spinal muscular atrophy, Biogen announced that NICE had agreed to evaluate Spinraza...
Roche has entered a licensing agreement Abcam which gives the British biotech exclusive access to the marketing rights for 760 of the Swiss pharma...
A district court in the US handed down a $5 million penalty and entered a permanent injunction to prevent Dr. Reddy’s from distributing prescription...
20,000 children in the UK have been left with disabilities due to the use of anticonvulsant sodium valproate by mothers during pregnancy in the...
Sanofi interest in making a big acquisition has been clear for the last few years and its struggles to solidify such desire into concrete results...
AstraZeneca has unveiled a double dose of approvals awarded to its medicines in Japan: Fasenra in asthma, and Lynparzain ovarian cancer.
Rumours of a $7billion Juno Therapeutics takeover by Celgene, accelerated approval in the US and Europe for Novartis' CAR T therapy Kymriah, and...
Novartis’ Sandoz unit had already staked a claim to being one of the leaders in the developing biosimilar market and has made another move to further...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches